A groundbreaking new clinical trial shines the spotlight on the potential of the marine ingredient fucoidan to relieve urinary symptoms associated with benign prostatic hyperplasia (BPH).
Partner Perspectives | Marinova
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Randomized Trial Reports Symptom Improvements With Standardized Shatavari Extract in Perimenopausal Women
2
Consumer Healthcare Products Association CEO to Step Down After 16 Years
3
Perelel Publishes New Clinical Data on Triple-Support Protein Formula
4
The Vitamin Shoppe Elevates Jack Gayton to Top Merchandising Post
5